TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 1, 2011, Pages

  Zimmermann, Maya ^a,h   Koreck, Andrea ^b   Meyer, Norbert ^a   Basinski, Tomasz ^a,g   Meiler, Flurina ^a   Simone, Burgler ^a   Woehrl, Stefan ^d   Moritz, Katharina ^d   Eiwegger, Thomas ^a,e   Schmid Grendelmeier, Peter ^f   Kemeny, Lajos ^b,c   Akdis, Cezmi A ^a,h  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d Universitatsklinik fur Dermatologie   (Austria)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^g WROCLAW MEDICAL UNIVERSITY   (Poland)

^h SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

Apoptosis; atopic dermatitis; eczema formation; Fn14; human primary keratinocytes; Psoriasis; TNF receptors; TNF like weak inducer of apoptosis; TNF

Indexed keywords

7 AMINODACTINOMYCIN; APOPTOSIS INDUCING FACTOR; DNA NUCLEOTIDYLEXOTRANSFERASE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR INDUCIBLE 14; LIPOCORTIN 5; TNF LIKE WEAK INDUCER OF APOPTOSIS; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ATOPIC DERMATITIS; CELL ACTIVITY; CELL ISOLATION; CONTROLLED STUDY; ECZEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 78650879440     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.11.005     Document Type: Article

References (39)

1. Q. Hamid, M. Boguniewicz, and D.Y. Leung Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis J Clin Invest 94 1994 870 876
2. M. Kristensen, C.Q. Chu, D.J. Eedy, M. Feldmann, F.M. Brennan, and S.M. Breathnach Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor Clin Exp Immunol 94 1993 354 362
3. A. Trautmann, M. Akdis, D. Kleemann, F. Altznauer, H.U. Simon, and T. Graeve T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis J Clin Invest 106 2000 25 35
4. G. Krueger, and C.N. Ellis Psoriasis - recent advances in understanding its pathogenesis and treatment J Am Acad Dermatol 53 suppl 2005 S94 100
5. S. Klunker, A. Trautmann, M. Akdis, J. Verhagen, P. Schmid-Grendelmeier, and K. Blaser A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis J Immunol 171 2003 1078 1084
6. C.A. Akdis, M. Akdis, T. Bieber, C. Bindslev-Jensen, M. Boguniewicz, and P. Eigenmann Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report J Allergy Clin Immunol 118 2006 152 169 (Pubitemid 43946480)
7. Y. Chicheportiche, P.R. Bourdon, H. Xu, Y.M. Hsu, H. Scott, and C. Hession TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis J Biol Chem 272 1997 32401 32410
8. L.C. Bover, M. Cardo-Vila, A. Kuniyasu, J. Sun, R. Rangel, and M. Takeya A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications J Immunol 178 2007 8183 8194
9. M.R. Chacon, C. Richart, J.M. Gomez, A. Megia, N. Vilarrasa, and J.M. Fernandez-Real Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity Cytokine 33 2006 129 137
10. D.H. Ho, H. Vu, S.A. Brown, P.J. Donohue, H.N. Hanscom, and J.A. Winkles Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice Cancer Res 64 2004 8968 8972
11. T. Kawakita, K. Shiraki, Y. Yamanaka, Y. Yamaguchi, Y. Saitou, and N. Enokimura Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis Biochem Biophys Res Commun 318 2004 726 733
12. T. Kawakita, K. Shiraki, Y. Yamanaka, Y. Yamaguchi, Y. Saitou, and N. Enokimura Functional expression of TWEAK in human colonic adenocarcinoma cells Int J Oncol 26 2005 87 93
13. M. Nakayama, N. Kayagaki, N. Yamaguchi, K. Okumura, and H. Yagita Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity J Exp Med 192 2000 1373 1380
14. L. Jin, A. Nakao, M. Nakayama, N. Yamaguchi, Y. Kojima, and N. Nakano Induction of RANTES by TWEAK/Fn14 interaction in human keratinocytes J Invest Dermatol 122 2004 1175 1179
15. V. Chaturvedi, J.Z. Qin, M.F. Denning, D. Choubey, M.O. Diaz, and B.J. Nickoloff Apoptosis in proliferating, senescent, and immortalized keratinocytes J Biol Chem 274 1999 23358 23367
16. N. Meyer, M. Zimmermann, S. Burgler, C. Bassin, S. Woehrl, and K. Moritz IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis J Allergy Clin Immunol 125 2010 858 865
17. T.M. Basinski, D. Holzmann, T. Eiwegger, M. Zimmermann, S. Klunker, and N. Meyer Dual nature of T cell-epithelium interaction in chronic rhinosinusitis J Allergy Clin Immunol 124 2009 74 80 e1-8
18. S. Burgler, N. Ouaked, C. Bassin, T.M. Basinski, P.Y. Mantel, and K. Siegmund Differentiation and functional analysis of human T(H)17 cells J Allergy Clin Immunol 123 2009 588 595 e1-7
19. M. Nakayama, K. Ishidoh, Y. Kojima, N. Harada, E. Kominami, and K. Okumura Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death J Immunol 170 2003 341 348
20. A. Wicovsky, S. Salzmann, C. Roos, M. Ehrenschwender, T. Rosenthal, and D. Siegmund TNF-like weak inducer of apoptosis inhibits proinflammatory TNF receptor-1 signaling Cell Death Differ 16 2009 1445 1459
21. S. Fulda, E. Meyer, and K.M. Debatin Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression Cancer Res 60 2000 3947 3956
22. M. Leverkus, M. Neumann, T. Mengling, C.T. Rauch, E.B. Brocker, and P.H. Krammer Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes Cancer Res 60 2000 553 559
23. D. Siegmund, P. Hadwiger, K. Pfizenmaier, H.P. Vornlocher, and H. Wajant Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumor cells for TRAIL-induced apoptosis Mol Med 8 2002 725 732
24. H. Wajant, E. Haas, R. Schwenzer, F. Muhlenbeck, S. Kreuz, and G. Schubert Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD) J Biol Chem 275 2000 24357 24366
25. A. Trautmann, P. Schmid-Grendelmeier, K. Kruger, R. Crameri, M. Akdis, and A. Akkaya T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma J Allergy Clin Immunol 109 2002 329 337
26. L.C. Burkly, J.S. Michaelson, K. Hahm, A. Jakubowski, and T.S. Zheng TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease Cytokine 40 2007 1 16
27. S. Kralisch, M. Ziegelmeier, A. Bachmann, J. Seeger, U. Lossner, and M. Bluher Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease Atherosclerosis 199 2008 440 444
28. M. Nagasawa, Z. Yi, S. Imashuku, S. Nonoyama, K. Ogawa, and K. Okumura Soluble TWEAK is markedly elevated in hemophagocytic lymphohistiocytosis Am J Hematol 83 2008 222 225
29. M.C. Park, S.J. Chung, Y.B. Park, and S.K. Lee Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis Scand J Rheumatol 37 2008 173 178
30. S.J. Perper, B. Browning, L.C. Burkly, S. Weng, C. Gao, and K. Giza TWEAK is a novel arthritogenic mediator J Immunol 177 2006 2610 2620
31. K. Yanaba, A. Yoshizaki, E. Muroi, T. Hara, F. Ogawa, and A. Usui Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis J Rheumatol 36 2009 1657 1662
32. M.I. Yilmaz, J.J. Carrero, A. Ortiz, J.L. Martin-Ventura, A. Sonmez, and M. Saglam Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease Clin J Am Soc Nephrol 4 2009 1716 1723
33. U. Trefzer, M. Brockhaus, H. Loetscher, F. Parlow, A. Kapp, and E. Schopf 55-kd tumor necrosis factor receptor is expressed by human keratinocytes and plays a pivotal role in regulation of human keratinocyte ICAM-1 expression J Invest Dermatol 97 1991 911 916
34. P. Diessenbacher, M. Hupe, M.R. Sprick, A. Kerstan, P. Geserick, and T.L. Haas NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2 J Invest Dermatol 128 2008 1134 1147
35. J.E. Vince, D. Chau, B. Callus, W.W. Wong, C.J. Hawkins, and P. Schneider TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFα J Cell Biol 182 2008 171 184
36. P. Schneider, R. Schwenzer, E. Haas, F. Muhlenbeck, G. Schubert, and P. Scheurich TWEAK can induce cell death via endogenous TNF and TNF receptor 1 Eur J Immunol 29 1999 1785 1792
37. M. Nakayama, K. Ishidoh, N. Kayagaki, Y. Kojima, N. Yamaguchi, and H. Nakano Multiple pathways of TWEAK-induced cell death J Immunol 168 2002 734 743
38. C.A. Wilson, and J.L. Browning Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis Cell Death Differ 9 2002 1321 1333
39. S. Burgler, N. Ouaked, C. Bassin, T.M. Basinski, P.Y. Mantel, and K. Siegmund Differentiation and functional analysis of human T(H)17 cells J Allergy Clin Immunol 123 2009 588 595 e1-7